GlassScriptPhysician profile
Stephanie H Shields
NPI 1538540364
$713.87
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $669 · 2021: $44.57.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $174.40 | 2019 | |
| Novo Nordisk INC | $134.64 | 2019 | |
| Pfizer INC. | $113.24 | 2019 | |
| Sanofi Pasteur INC. | $50.00 | 2019 | |
| Amgen INC. | $47.51 | 2019 | |
| Abbvie INC. | $30.66 | 2021 | |
| Shire North American Group INC | $30.50 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.47 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.19 | 2019 | |
| Lilly USA, LLC | $13.91 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.14 | 2019 | |
| Upsher-Smith Laboratories LLC | $13.06 | 2019 | |
| Radius Health, INC. | $12.81 | 2019 | |
| Neuronetics, INC. | $11.26 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.10 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $10.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Shields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.